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ABSTRACT 
Skeletal muscle (SKM) is an important regulator of metabolism and adaptations from exercise training 
influences mitochondrial function. Thyroid hormone (TH) is a regulator of SKM processes, including 
mitochondrial biogenesis. PURPOSE: To use an in vitro model of hypothyroidism to test the hypothesis that 
SKM cells will have dysregulated mitochondrial homeostasis. Additionally, the exercise mimetic, 
formoterol, was used to determine the effects of exercise signaling on mitochondrial biogenesis.  
METHODS: Human SKM myoblasts (n = 6 per group) were cultured and differentiated until mature 
myotube formation (Day 6). Groups included control cells (CON), TH depleted cells (ThD), and TH depleted 
cells plus formoterol stimulation (ThD+F; 30nM for 3h). Total RNA was extracted during mid-myogenesis 
(Day 4) and at terminal differentiation (Day 6). Gene expression for Peroxisome Proliferator-Activated 
Receptor Gamma Coactivator-1 Alpha (PGC-1α), Mitochondrial Transcription Factor A (TFAM), and 
Nuclear Respiratory Factor 1 (NRF1) was determined by qPCR. Data was analyzed by repeated measures 
ANOVA. RESULTS: PGC-1α: D4 ThD was decreased compared to D4 ThD+F (-4.6); D4 ThD+F was 
increased compared to D4 CON (4.6); D6 CON was decreased compared to D6 ThD+F (-2.9); D6 ThD was 
decreased compared to D6 ThD+F (-3.7). TFAM: D4 ThD+F was greater than D4 CON (3.6); D4 ThD+F was 
greater than D6 ThD+F (3.6); D6 ThD was decreased compared to D6 CON (-0.55); D6 ThD+F was decreased 
compared to D6 CON (-0.63). NRF1: D4 ThD was decreased compared to D4 CON (-0.31); D4 ThD was 
greater than D4 ThD+F (0.36); D4 ThD was greater than D6 ThD (0.17); D4 ThD+F was decreased compared 
to D4 CON (-0.67); D6 CON was decreased compared to D4 CON (-0.18); D6 ThD was decreased compared 
to D6 CON (-0.3); D6 ThD+F was decreased compared to D6 CON (-0.42). All reported differences are 
significant (p < 0.05). Data are expressed as fold changes. CONCLUSION: ThD media resulted in reduced 
NRF1 signaling in both D4 and D6 with a subsequent decrease in D6 only for TFAM. Formoterol resulted in 
the expected stimulation of PGC-1α at both D4 and D6, but subsequent signaling for genes associated with 
mitochondrial biogenesis common to PGC-1α stimulation were lost as a result of TH depletion at D6 only 
for TFAM and both D4 and D6 for NRF1. 
